Atara Biotherapeutics Inc ATRA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/07/21 EDT
13.59UNCH (UNCH)
Volume
67,709
Close
13.59quote price arrow up+0.70 (+5.43%)
Volume
725,770
52 week range
8.67 - 28.20

...

Loading . . .
  • Open13.01
  • Day High13.62
  • Day Low13.00
  • Prev Close12.89
  • 52 Week High28.20
  • 52 Week High Date12/07/20
  • 52 Week Low8.67
  • 52 Week Low Date05/07/20

Key Stats

  • Market Cap1.143B
  • Shares Out84.08M
  • 10 Day Average Volume0.95M
  • Dividend-
  • Dividend Yield-
  • Beta2.40
  • YTD % Change-30.77

KEY STATS

  • Open13.01
  • Day High13.62
  • Day Low13.00
  • Prev Close12.89
  • 52 Week High28.20
  • 52 Week High Date12/07/20
  • 52 Week Low8.67
  • 52 Week Low Date05/07/20
  • Market Cap1.143B
  • Shares Out84.08M
  • 10 Day Average Volume0.95M
  • Dividend-
  • Dividend Yield-
  • Beta2.40
  • YTD % Change-30.77

RATIOS/PROFITABILITY

  • EPS (TTM)-3.86
  • P/E (TTM)-3.52
  • Fwd P/E (NTM)-3.70
  • EBITDA (MRQ)-303.921M
  • ROE (MRQ)-95.56%
  • Revenue (MRQ)3.55M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-8,768.19%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Atara Biotherapeutics Inc

There is no recent news for this security.

Profile

MORE
Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for patients with severe and life-threatening diseases. The Company operates through the business of developing and commercializing therapeutics segment. The Company is focused on developing allogeneic or third-party derived antigen-specific T-cells. T-cells are a type of white blood cell. The Company's product candidate, ATA129, is a third-party derived...
Ronald Renaud Jr.
Chairman
Pascal Touchon
President
Joseph Newell
Chief Operating Officer
Utpal Koppikar
Chief Financial Officer
Address
611 Gateway Blvd Ste 900
South San Francisco, CA
94080-7015
United States

Top Peers

SYMBOLLASTCHG%CHG
STOK
Stoke Therapeutics Inc
32.46+1.07+3.41%
CLDX
Celldex Therapeutics Inc
27.31+0.74+2.79%
CRTX
Cortexyme Inc
37.10+0.42+1.15%
KNSA
Kiniksa Pharmaceuticals Ltd
14.63+0.01+0.07%
VXRT
Vaxart Inc
7.20+0.27+3.90%